1.
Analysis on the Opportunities and Challenges Facing Biopharmaceutical Companies in China;
中国生物制药企业面临的机遇和挑战
2.
Technology Innovation Decision Model for Bio-pharmaceutical Enterprises Based on Entropy;
基于熵的生物制药企业技术创新决策模型研究
3.
The Present Situation and Countermeasures for Continuous Technological Innovation of Biopharmaceutical Enterprises in China;
我国生物制药企业持续技术创新的现状与对策
4.
Risk-Resistant Function of OEM in GMP s Attestation of Biological Pharmacy Enterprises;
OEM在生物制药企业GMP认证中的抗风险作用
5.
Evaluation of Biopharmaceutical Enterprises Based on Value Chain Analysis
基于价值链分析的生物制药企业价值评估
6.
Public Policies of Government on the Growth of Biopharmaceutical Companies in Kunming Study on the Factors Affecting
政府公共政策对生物制药企业成长的影响因素研究
7.
Pattern of Absorbing New Technologies in Chinese Biological Pharmaceutical Companies
我国生物制药企业引进消化吸收再创新模式研究
8.
Analysis of Bio-pharmaceutical Industry s Status and Strategy for Domestic Enterprises;
生物制药产业现状分析及我国企业的发展战略
9.
Practical Strategy of Retaining Key Employees for Biochemical/Pharmaceutical Enterprises;
生物化工/制药企业保留核心员工实战策略
10.
Research of Chinese Pharmaceutical Enterprise Novel Drug Development Strategy;
我国制药企业创新药物研发战略研究
11.
The Relationship among Business Environment and Knowledge Management Strategy with Enterprise Performance--Taking Chongqing Biology Parmacy Industry as the Case;
企业环境、知识管理战略与企业绩效的关联性研究——以重庆生物制药行业为例
12.
Pharmcoeconomics of Overseas Pharmaceutical Enterprise and its Use for Reference;
国外制药企业的药物经济学研究及其借鉴
13.
Study on symbiosis relationship between manufacturer and logistic company;
制造企业与物流服务企业的共生关系
14.
The Teaching of the Medicinal Chemsitry Course for Bio-pharmaceutical Specialty
生物制药专业课程中的药物化学教学的探讨
15.
Discussed Shallowly the Drugs Manufacture Enterprise Material Supplier Chooses and Audit;
浅谈制药企业的物料供应商选择及审核
16.
Pharmaceutical chain operator means of logistics cost control
医药连锁经营企业物流成本控制的途径
17.
Teaching Methods Discussion of Biotechnological Pharmacy in Pharmacy Vocational Education;
高职药学专业生物制药学教学方法初探
18.
With regard to biopharmaceuticals, the group has invested in European and the US biotechs that will soon be listed on the stock exchange.
在生技制药领域日渐蓬勃发展下，集团内投资欧美各国发展生物科技且即将上市的相关企业。